AUTOTAC Bio

CEO

PhD 권용태
- CEO, AUTOTAC Bio Inc.
- PhD in Molecular Biology, Seoul National University
- MS in Molecular Biology, Seoul National University
- Director, Cellular Degradation Biology Center, Seoul National University
- Professor (tenure), Seoul National University
- Associate Professor (tenure), University of Pittsburgh
- Senior Scientist, Key Staff, California Institute of Technology

R&D

PhD 김현태
- Executive Director, Institute for Chemistry R&D Center
- PhD in Structural Biology, College of Life Sciences and Biotechnology, Korea University
- Protein structure determination and modelling study
- Member of CDISC_K3C (Korean CDISC Coordinating Committee)
- Former Biology Senior Leader, CrystalGenomics R&D
- (License out) 1) 454 M USD : oral anemia medication / hypoxia to ProQuest investment 2) 331 M USD: CG806 (AML) to Aptose
- (New drug development) Acelex, the 22nd developed medicine in Korea. Identifed MOA of Acelex.
PhD 최설민
- Executive Director, Medicine Development Center
- PhD in Toxicology, School of Pharmacy, Sungkyunkwan University
- BS, Biological Sciences, Sungkyunkwan University
- Project leader for sarcopenia, dyslipidemia, gastritis/Project team member of Zydena and Stillen at Dong-A ST
- External Panel of National Research Council of Science & Technology (NIS)
- Member of KSOT/KEMS, KSAP, KSNS
PhD 지창훈
- Director, Bio R&D Center
- PhD in Biomedical Science, School of Medicine, Seoul National University
- BS, Biomedical Engineering, Johns Hopkins University
- BS, Applied Mathematics and Statistics, Johns Hopkins University
- In vitro biological evaluation & platform biology development
- Cellular & molecular biology
PhD candidate 성기운
- Director, Institute for Clinical and Translational Research Center
- PhD candidate, School of Medicine, Seoul National University
- BS, Physical Education, Sejong University
- In vivo efficacy & toxicity evaluation
- Adjunct Faculty in Kwangwoon University
- Academician, Korean Society exercise nutrition
MS/Veterinarian 정한국
- Medicine Development Center
- MS in Veterinary Pathology, College of Veterinary Medicine, Seoul National University
- BS, College of Veterinary Medicine, Seoul National University
- Nonclinical toxicology
MS 박창민
- Institute for Chemistry R&D Center
- MS in Organic Chemistry, Department of Chemistry, Yonsei University
- Former Deputy General Manager, Department of Organic Synthesis, Kukjepharma
- Medicinal chemistry, CMC and process development
MS 나정은
- Institute for Chemistry R&D center
- MS in Organic Chemistry, Department of Chemistry, Chonnam National University
- Medicinal chemistry research (design and synthesis, CRO management)
PhD/KO Pharmacist 이재민
- Medicine Development Center
- PhD in Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
- BS, Oriental Pharmaceutical Science, Kyunghee University
- Nonclinical development

Management Support

CPA/CTA 구자영
- CFO & Executive Director, Financial Management Division
- BA, Business Administration, Korea University
- Audit, tax, financial advice (due diligence, valuation) in PwC Korea
- Fundraising, planning, risk management in Shinhan Venture Investment
- Accounting, tax, treasury in Doosan Capital
- Start-up financial advisory service as Virtual CFO
MBA/MS 박영경
- CBO & Executive Director, Business Development
- KHIDI emerging market global business development advisor
- Alliance management and license in and out co-development partnership with various multi-national companies. (E.G. Sanofi, GSK, Lilly and etc.)
BSN 이송이
- Business Development
- RN in Australia, New Zealand and Korea
- Licensing, business strategy and alliance management, clinical trial operation
- 15 years of experience in hospital, healthcare and biotech industry
　　 이효정
- Financial Management Division
- Accounting, tax and asset management
- Human resources management